A curated resource of human genes associated with ID, autism, ADHD, schizophrenia, bipolar disorder, and epilepsy. This dataset includes both loss of function and missense mutations associated with DBDs.
| ID/DD| Autism| Epilepsy| ADHD| Schizophrenia| Bipolar Disorder| |-----:|------:|--------:|----:|-------------:|----------------:| | 74| 287| 13| 215| 331| 70|
A database of gene-disease associations from public data sources and the literature. Includes data from UniProt, CGI, ClinGen, Genomics England Panel App, PsyGeNET, Orphanet, HPO, and CTD. Genes compiled using the BeFree System are extracted from MEDLINE abstracts.
| autism| intellectual disability| attention deficit hyperactivity disorder| schizophrenia| bipolar disorder| epilepsy| |------:|-----------------------:|----------------------------------------:|-------------:|----------------:|--------:| | 433| 1279| 308| 1028| 513| 804|
SFARI is an online database of human and animal genes associated with autism.
| Human Gene | Animal Gene| |-----------:|-----------:| | 859| 189|
The University of Rochester Medical Center (URMC) Developmental Brain Disorders Database (DBDB) is a databse of DBD-associated genes intended for use by clinician-scientists.
| autism| intellectual disability| epilepsy| |------:|-----------------------:|--------:| | 52| 239| 143|
G2P is an online database designed to facilitate the development, validation, curation and distribution of large-scale, evidence-based datasets for use in diagnostic variant filtering. Each G2P entry associates an allelic requirement and a mutational consequence at a defined locus with a disease entity. A confidence level and evidence link are assigned to each entry. The Developmental Disease (DD) database used to identify genes associated with autism, intellectual disability, and epilepsy was curated by Helen V Firth and David FitzPatrick.
| autism| intellectual disability| epilepsy| |------:|-----------------------:|--------:| | 16| 126| 54|
Analysis of de novo CNVs (dnCNVs) from the full Simons Simplex Collection (SSC) (N = 2,591 families) provides strong evidence that de novo mutations are associated with ASD apart from the risk for intellectual disability. Extending the transmission and de novo association test (TADA) to include small de novo deletions reveals 71 ASD risk loci, and 65 risk genes (FDR ≤ 0.1). These genes were mapped to 67 homologous mouse ASD-genes.
| autism| |------:| | 67|
Satterstrom et al., present the largest exome sequencing study of autism spectrum disorder (ASD) to date (n = 35,584 total samples, 11,986 with ASD). The authors identify 102 risk genes (FDR<0.1). These risk genes appear to be expressed early in brain development, and involved in neurodevelopmental and neuronal communication. In cells from the human cortex, risk genes are enriched in excitatory and inhibitory neuronal cell lineages.
| autism| |------:| | 96|
Genes associated with human epilepsies were compiled from the literature and several online databases.
| Epilepsy Syndromes | Neurodevelopment| Epilepsy-Related| Potential| All| |-------------------:|----------------:|----------------:|---------:|---:| | 80| 222| 513| 251| 915|
Geladaki et al., develop the LOPIT-DC method to identify the subcellular localization of proteins in complex biological samples.
Differentially expressed genes identified by single cell RNA sequencing of Human ASD brain samples. Human genes were mapped to 433 mouse genes that are differentially expressed genes (DEGs).
|Cell Type | N Genes| |:-----------------------|-------:| |AST-FB DEGs | 14| |AST-PP DEGs | 44| |Endothelial DEGs | 55| |IN-PV DEGs | 27| |IN-SST DEGs | 26| |IN-SV2C DEGs | 32| |IN-VIP DEGs | 71| |L2/3 DEGs | 91| |L4 DEGs | 78| |L5/6 DEGs | 8| |L5/6-CC DEGs | 16| |Microglia DEGs | 64| |Neu-mat DEGs | 2| |Neu-NRGN-I DEGs | 12| |Neu-NRGN-II DEGs | 23| |Oligodendrocytes DEGs | 13| |OPC DEGs | 2| |ASD DEGs | 433| |ASD Up-regulated DEGs | 388| |ASD Down-regulated DEGs | 190|
Cell types defined by single cell RNA sequencing of human brains.
|Cell Type | Genes| |:----------------|-----:| |AST-FB | 2448| |AST-PP | 5116| |Endothelial | 1114| |IN-PV | 1937| |IN-SST | 2096| |IN-SV2C | 1008| |IN-VIP | 3259| |L2/3 | 7024| |L4 | 3528| |L5/6 | 1727| |L5/6-CC | 2343| |Microglia | 1509| |Neu-mat | 2148| |Neu-NRGN-I | 1514| |Neu-NRGN-II | 3586| |Oligodendrocytes | 5767| |OPC | 5333|
Compiled genes from the SynGO database.
Sharma et al., performed high-resolution mass spectrometry proteomics to obtain an in-depth profile of the mouse brain proteome. A comparison of all proteins identified and with transcriptome data indicates that a deep coverage of the total mouse brain proteome was achieved. Below is a summary of brain region-specific proteins (FE>10).
|Brain Region | Genes| |:-------------------|-----:| |Total Brain | 2872| |Brainstem | 499| |Cerebellum | 2241| |Corpus Callosum | 3| |Hippocampus | 358| |Motor Cortex | 382| |Olfactory Bulb | 799| |Optic Nerve | 586| |Striatum | 156| |Thalamus | 1|
A proteome of the inhbitory post-synaptic density (iPSD) generated by in vivo proximity proteomics. Summary of iPSD identified by Arhgef9, Gephyrin, and InSyn1 iBioID:
| Arhgef9| Gphn| InSyn1| iPSD| |-------:|----:|------:|----:| | 74| 90| 85| 181|
A inhibitory postsynaptic (iPSD) proteome compiled from 5 different studies.
| Heller et al., 2012| Kang et al., 2014| Loh et al., 2016| Nakamura et al., 2016| Uezu et al., 2016| All Studies| |-------------------:|-----------------:|----------------:|---------------------:|-----------------:|-----------:| | 18| 74| 38| 171| 181| 413|
Proteome of synaptic GAPs and GEFs.
| Syngap1| Agap2| Kalrn| |-------:|-----:|-----:| | 124| 103| 53|
310 mouse genes likely disrupting gene disrupting mutations in human individuals with autism.
93 Autism associated genes.
419 genes
|Study |Reference | N Genes| |:-----------------|:------------------------------------------------------------|-------:| |arrabroadwave3ASD |ref^ | 58| |deligt2012ID |ref | 55| |girard2011SZ |ref | 14| |gulsuner2013SZ |ref | 64| |iossifov2012ASD |ref | 230| |neale2012ASD |ref | 103| |oroak2012ASD |ref | 167| |rauch2012ID |ref | 69| |sanders2012ASD |ref | 127| |xu2012SZ |ref | 119| ^ ARRA Autism Sequencing Colloraboration
|Category | N Genes| |:----------------------------------|-------:| |post:CELL ADH TRANS SIGN | 131| |post:CELL METABOLISM | 183| |post:ENDOCYTOSIS | 22| |post:EXCITABILITY | 33| |post:EXOCYTOSIS | 25| |post:GPCR SIGNALING | 30| |post:INTRACELL SIGN TRANSDUC | 297| |post:INTRACELLULAR TRAFFICKING | 47| |post:ION BALANCE/TRANSPORT | 100| |post:LGIC SIGNALING | 54| |post:NEUROTRANSMITTER METABOLISM | 8| |post:PEPTIDE/NEUROTROPHIN SIGNALS | 3| |post:PROT CLUST | 103| |post:RPSFB | 228| |post:STRUCTURAL PLASTICITY | 174| |post:TYR KINASE SIGN | 32| |post:TYR KINASE SIGNALING | 9| |post:UNKNOWN | 123| |pre:CELL ADH TRANS SIGN | 104| |pre:CELL METABOLISM | 4| |pre:ENDOCYTOSIS | 105| |pre:EXCITABILITY | 94| |pre:EXOCYTOSIS | 186| |pre:G-PROTEIN RELAY | 53| |pre:GPCR SIGNALING | 87| |pre:INTRACELL SIGN TRANSDUC | 230| |pre:INTRACELLULAR TRAFFICKING | 132| |pre:ION BALANCE/TRANSPORT | 22| |pre:LGIC SIGNALING | 78| |pre:NEUROTRANSMITTER METABOLISM | 42| |pre:PEPTIDE/NEUROTROPHIN SIGNALS | 75| |pre:PROT CLUST | 71| |pre:STRUCTURAL PLASTICITY | 155| |pre:UNKNOWN | 82| |unspec:CELL ADH TRANS SIGN | 77| |unspec:ENDOCYTOSIS | 55| |unspec:EXCITABILITY | 58| |unspec:EXOCYTOSIS | 119| |unspec:G-PROTEIN RELAY | 105| |unspec:GPCR SIGNALING | 17| |unspec:INTRACELL SIGN TRANSDUC | 241| |unspec:INTRACELLULAR TRAFFICKING | 84| |unspec:ION BALANCE/TRANSPORT | 41| |unspec:LGIC SIGNALING | 83| |unspec:NEUROTRANSMITTER METABOLISM | 17| |unspec:PROT CLUST | 117| |unspec:STRUCTURAL PLASTICITY | 139| |unspec:UNKNOWN | 100| |post | 693| |pre | 752| |unspec | 602|
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.